Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 50 Women only

Iron-for-pregnant-women: Vir and Fer injections compared

Official title: Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia (Hb<9)

Run by Western Galilee Hospital-Nahariya · NCT06061393 · Data updated 2026-11-12

This study tests whether Ferinject works as well as Venofer for pregnant women with iron-deficiency anemia who are at least 24 weeks pregnant.

More Iron Deficiency trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 50 Years
SexWomen only
Enrollment200 (estimated)
SponsorWestern Galilee Hospital-Nahariya
Government
Locations1 site (Nahariya)
StatusRecruiting
StartedNovember 2, 2023
Main results expectedSeptember 2027
Study endsDecember 2027
Registry record updatedSeptember 11, 2026
Trial IDNCT06061393 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Pregnant women at 24 weeks or later with iron-deficiency anemia (Hb < 9 g/dL, or < 9.5 g/dL if symptomatic or prior postpartum hemorrhage).

Probably not a fit

Women with non-iron-deficiency anemia, twin pregnancies, recent IV iron treatment, or certain medical conditions may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional Phase 4 trial compares two iron therapies for pregnant women with iron-deficiency anemia and low hemoglobin. Participants are assigned to receive either Venofer or Ferinject, with outcomes including hemoglobin levels and the need for blood transfusions before and after delivery. Eligibility focuses on late-pregnancy anemia (Hb < 9, or < 9.5 if symptomatic or prior postpartum hemorrhage) and excludes those with certain conditions or twin pregnancies. The lead site is Western Galilee Hospital in Nahariya, with Galilee Medical Center as a participating location.

Why it matters

Potential benefit: If Ferinject is as effective as Venofer, this could offer an alternative treatment option for managing iron-deficiency anemia in late-pregnancy.

How similar studies have gone: Prior studies have explored IV iron therapies in pregnancy with mixed results; this trial examines a direct comparison in a real-world Phase 4 setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

pregnancy\>24 weeks of gestation anemia with Hb\<9 anemia with Hb\<9.5 if symptomatic anemia or previous postpartum hemorrhage

Exclusion Criteria:

* Allergy to one of the study's drugs
* IV iron treatment in the last month
* Underlying medical conditions associated with anemia, such as thalassemia Major, renal insufficiency, or spherocytosis
* Twin pregnancy
* non iron deficiency anemia

Where it's running

  • Galilee Medical Center
    Nahariya, Israel
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.